| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/23/2013 | CA2539068C Hiv vaccines based on env of multiple clades of hiv |
| 07/23/2013 | CA2537793C Adeno-associated virus (aav) clades, sequences, vectors containing same, and uses therefor |
| 07/23/2013 | CA2517439C Polysaccharide - staphylococcal surface adhesin carrier protein conjugates for immunization against nosocomial infections |
| 07/23/2013 | CA2514646C Factor viii polypeptide |
| 07/23/2013 | CA2487351C Export and modification of (poly)peptides in the lantibiotic way |
| 07/23/2013 | CA2438886C Fusion protein for the secretion of a protein of interest into the supernatant of the bacterial culture |
| 07/23/2013 | CA2428114C Apolipoprotein analogues |
| 07/23/2013 | CA2321106C Group b streptococcus antigens |
| 07/23/2013 | CA2250835C Novel ectoparasite saliva proteins and apparatus to collect such proteins |
| 07/18/2013 | WO2013106819A2 Zinc-responsive peptides, and methods of use thereof |
| 07/18/2013 | WO2013106639A1 Crysral structure of hcv polymerase complexes and methods of use |
| 07/18/2013 | WO2013106489A1 Humanized antibodies with ultralong cdr3s |
| 07/18/2013 | WO2013106273A2 Peptides and methods of using same |
| 07/18/2013 | WO2013106175A1 Variant activin receptor polypeptides, alone or in combination with chemotherapy, and uses thereof |
| 07/18/2013 | WO2013105089A2 Anti-inflammatory peptides and use thereof |
| 07/18/2013 | WO2013104929A1 Peptides and peptide derivatives based on xenin |
| 07/18/2013 | WO2013104901A2 Novel therapies |
| 07/18/2013 | WO2013104728A1 Novel pseudotyped lentiviral particles and their use in the in vitro targeted transduction of undifferentiated pluripotent human embryonic stem cells and induced pluripotent stem cells |
| 07/18/2013 | WO2013104687A2 A modified collagen |
| 07/18/2013 | WO2013104686A1 Cellular high throughput encapsulation for screening or selection |
| 07/18/2013 | WO2013104648A1 Method to identify ligands for sigma-1 receptors |
| 07/18/2013 | WO2013104586A1 Methods for preventing, treating or diagnosing disorders |
| 07/18/2013 | WO2013104424A1 Synthetic genes encoding peptide fragments of natural myelin proteins for induction of oral tolerance, dna fragment comprising these genes, means of obtaining these peptides in a microbial (bacterial) system and their medical application |
| 07/18/2013 | WO2013104102A1 Breast cancer diagnosis and indication marker |
| 07/18/2013 | WO2013076687A3 Recombinant nitrogen-fixing bacterial strain, inoculum containing the same and application methods |
| 07/18/2013 | WO2013061091A3 Cystic fibrosis treatment |
| 07/18/2013 | WO2013050048A3 Identification and attenuation of the immunosuppressive domains in fusion proteins of enveloped rna viruses |
| 07/18/2013 | WO2013042156A3 Peptides having protective effect towards the inflammatory activity of peptide 31-43 of a-gliadin in celiac disease |
| 07/18/2013 | WO2013030678A3 Modified toll-like receptor 2 (tlr2) ligands as inhibitors of neutrophil recruitment |
| 07/18/2013 | WO2012159187A3 Denv-derived peptides and methods for the inhibition of the flavivirus replication |
| 07/18/2013 | US20130185831 Nucleic Acid Molecules and Other Molecules Associated with Plants and Uses Thereof for Plant Improvement |
| 07/18/2013 | US20130184443 Methods for Preparing Conjugates |
| 07/18/2013 | US20130184438 Mutant protein |
| 07/18/2013 | US20130184437 Design and use of new recombinant interferons with altered spatial configuration and three-dimensional structure |
| 07/18/2013 | US20130184434 Peptide Toxin Formulation |
| 07/18/2013 | US20130184333 Growth factor isoform |
| 07/18/2013 | US20130184212 Fibronectin based scaffold proteins having improved stability |
| 07/18/2013 | US20130184210 Variants derived from actriib and uses therefor |
| 07/18/2013 | US20130184208 BMP Mutants with Decreased Susceptibility to Noggin |
| 07/18/2013 | US20130184207 Long-acting polypeptides and methods of producing and administering same |
| 07/18/2013 | US20130184203 Glp-1 receptor agonist compounds having stabilized regions |
| 07/18/2013 | US20130184202 Peptide Inhibitors and Methods of Use Thereof |
| 07/18/2013 | US20130184200 Immunogenic Polypeptides and Monoclonal Antibodies |
| 07/18/2013 | US20130183754 NUCLEIC ACID CONSTRUCT CONTAINING A NUCLEIC ACID DERIVED FROM THE GENOME OF HEPATITIS C VIRUS (HCV) OF GENOTYPE 2a, AND A CELL HAVING SUCH NUCLEIC ACID CONSTRUCT INTRODUCED THEREIN |
| 07/18/2013 | US20130183689 Method for detecting and removing endotoxin |
| 07/18/2013 | US20130183688 Tim-3 ligands and methods thereof |
| 07/18/2013 | US20130183673 New markers for the epithelial and proliferative or mesenchymal invasive phenotype of human neoplasias |
| 07/18/2013 | US20130183385 Peptide analogs for treating diseases and disorders |
| 07/18/2013 | US20130183378 CD133 Epitopes |
| 07/18/2013 | US20130183342 Computationally optimized broadly reactive antigens for influenza |
| 07/18/2013 | US20130183332 Treatment and Prevention of Malaria |
| 07/18/2013 | US20130183331 Immunogenic proteins from genome-derived outer membrane of leptospira and compositions and methods based thereon |
| 07/18/2013 | US20130183327 Compositions including i-domain antigen conjugate compounds and methods for treatment of autoimmune disorders |
| 07/18/2013 | US20130183326 Methods and compositions for modulating the activity of the interleukin-35 receptor complex |
| 07/18/2013 | US20130183298 Methods of Treating Hepatitis With Anti-TNF alpha Antibodies |
| 07/18/2013 | US20130183287 Protein binding domains stabilizing functional conformational states of gpcrs and uses thereof |
| 07/18/2013 | US20130183265 Mia-2 protein |
| 07/18/2013 | US20130183241 Peptides that home to tumor lymphatic vasculature and methods of using same |
| 07/18/2013 | US20130183237 Thrombin inhibitor |
| 07/18/2013 | CA2860864A1 Method for modulating plant root architecture |
| 07/18/2013 | CA2860852A1 Cellular high throughput encapsulation for screening or selection |
| 07/18/2013 | CA2860843A1 Methods for preventing, treating or diagnosing disorders |
| 07/17/2013 | EP2615455A1 Translation and construction of non-standard peptide compound library containing n-methyl amino acids and other non-standard amino acids, and method for searching for active species |
| 07/17/2013 | EP2615176A1 Novel pseudotyped lentiviral particles and their use in the in vitro targeted transduction of undifferentiated pluripotent human embryonic stem cells and induced pluripotent stem cells |
| 07/17/2013 | EP2615162A1 Culture method and culture device |
| 07/17/2013 | EP2615112A2 Purified immunoglobulin fusion proteins and methods of their purification |
| 07/17/2013 | EP2615111A1 Method to identify ligands for sigma-1 receptors |
| 07/17/2013 | EP2615110A1 Biomarker for diagnosing cancer and method of isolating cancer cell using the same |
| 07/17/2013 | EP2615109A1 Localized pegylated modifications of exendin-4 analogs and use thereof |
| 07/17/2013 | EP2615108A1 Modified human plasma polypeptide or fc scaffolds and thier uses |
| 07/17/2013 | EP2615107A1 A novel biopolymer having excellent tensile strength, extensibility and toughness |
| 07/17/2013 | EP2615106A1 Engineered cleavage half-domains |
| 07/17/2013 | EP2614836A2 High growth reassortant influenza A virus |
| 07/17/2013 | EP2614151A1 Interleukin 15 as selectable marker for gene transfer in lymphocytes |
| 07/17/2013 | EP2614079A1 Mutant channelrhodopsin 2 |
| 07/17/2013 | EP2614078A1 Stem cell culture media and methods |
| 07/17/2013 | EP2614077A1 Chimeric antigen receptors with an optimized hinge region |
| 07/17/2013 | EP2614076A1 Modified relaxin polypeptides |
| 07/17/2013 | EP2614075A1 Single chain relaxin polypeptides |
| 07/17/2013 | EP2614074A1 Methods and compositions involving protective staphylococcal antigens |
| 07/17/2013 | EP2614073A1 Recombinant bacterial lipocalin blc and uses thereof |
| 07/17/2013 | EP2614072A2 Human cytomegalovirus vaccine |
| 07/17/2013 | EP2613807A1 Foot and mouth disease virus with increased stability and its use as vaccine |
| 07/17/2013 | EP2613806A1 Non-lipidated variants of neisseria meningitidis orf2086 antigens |
| 07/17/2013 | EP2613796A2 Compounds and methods |
| 07/17/2013 | EP2613650A1 A thaumatin-based improved sweetening composition and edible products made therewith |
| 07/17/2013 | EP2261380B1 Method of preventing virus:cell fusion by inhibiting the function of the fusion initiation region in rna viruses having class I membrane fusogenic envelope proteins |
| 07/17/2013 | CN1568329B Immunogenic peptide composition for the prevention and treatment of Alzheimer's disease |
| 07/17/2013 | CN103209992A Factor viii variants having a decreased cellular uptake |
| 07/17/2013 | CN103209991A Method for producing highly concentrated solutions of self-assembling proteins |
| 07/17/2013 | CN103209990A Recombinant hemagglutinin protein of influenza virus and vaccine containing the same |
| 07/17/2013 | CN103209989A Cyclic peptide compound or pharmacologically acceptable salt thereof and method for producing same |
| 07/17/2013 | CN103209711A Double-acylated GLP-1 derivatives |
| 07/17/2013 | CN103209706A Methods to produce bunyavirus replicon particles |
| 07/17/2013 | CN103209701A Immunogenic vaccine |
| 07/17/2013 | CN103205439A Expression and application of harpinZPsgA1 protein of Pseudomonas syringae pv. glycinea |
| 07/17/2013 | CN103205438A OVATE gene sequence related to fruit shape control of eggplant |
| 07/17/2013 | CN103205432A Disseminated superficial actinic porokeratosis (DSAP) related gene |
| 07/17/2013 | CN103204925A Synthetic method of general artificial antigen of phthalate plasticizers for immunodetection |
| 07/17/2013 | CN103204924A Method for preparing malachite green oxalate artificial antigen |